Prev Arrow Stocks

IDEXX Laboratories Inc. ($IDXX) Stock Forecast: Up 9.0% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is IDEXX Laboratories Inc.?

IDEXX Laboratories (IDXX) is a leading provider of veterinary diagnostics and software solutions for animal health. The company has shown consistent growth and innovation in the veterinary healthcare industry.

Why is IDEXX Laboratories Inc. going up?

IDXX stock is up 9.0% on May 1, 2025 17:12

  • Strong Q1 earnings were reported by IDXX, surpassing expectations and resulting in an increased outlook for the fiscal year 2025. This positive financial performance has led to heightened investor interest and a rise in the stock price.
  • Over the past decade, IDXX has consistently outperformed the market, achieving an impressive annualized return of 21.28%. This track record has likely fostered investor confidence in the company's future growth prospects.
  • The notable financial results and a history of market-beating returns have fueled a positive trend in IDXX stock, reflecting optimistic investor attitudes and confidence in the company's future prospects.

IDXX Price Chart

IDXX Technical Analysis

IDXX News

IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.

https://www.zacks.com/stock/news/2460343/idxx-q1-earnings-beat-fy25-view-raised-stock-up-in-pre-market

0 Missing News Article Image IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Laboratories IDXX has outperformed the market over the past 10 years by 11.03% on an annualized basis producing an average annual return of 21.28%. Currently, IDEXX Laboratories has a market capitalization of $35.41 billion.

https://www.benzinga.com/insights/news/25/04/45088295/heres-how-much-100-invested-in-idexx-laboratories-10-years-ago-would-be-worth-today

1 News Article Image Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - IDEXX Laboratories  ( NASDAQ:IDXX )

IDEXX Laboratories Inc. Price History

21.07.2024 - IDXX Stock was down 0.6%

  • The downward trend in IDXX today may be due to the following reasons:
  • Profit-taking: Investors who have realized substantial profits from holding IDXX stock for an extended period may have opted to sell shares to secure their gains, resulting in a decrease in the stock price.
  • Market correction: Following a period of sustained success, IDXX might be undergoing a natural market correction as investors review their positions and explore new investment prospects.
  • External influences: Economic conditions or industry-related developments could also be impacting the bearish movement in IDXX today, prompting investors to modify their investment portfolios accordingly.

30.00.2025 - IDXX Stock was up 5.2%

  • IDXX's upturn today is linked to market expectations of robust Q4 earnings, attributed to the company's successful execution of strategic initiatives.
  • Investors are positive about IDXX's outlook, anticipating growth and profitability in the upcoming period.
  • The favorable outlook for IDXX mirrors the market's confidence in the company's capability to deliver value and sustain a competitive position in the veterinary diagnostics sector.

31.09.2024 - IDXX Stock was down 9.5%

  • Third-quarter earnings of IDXX surpassed adjusted EPS predictions but fell short of revenue consensus, hinting at possible hurdles in revenue expansion.
  • The deceleration in revenue growth is possibly linked to a decline in veterinary visits, influencing the company's sales trajectory.
  • Noteworthy growth in segments such as CAG and Water was eclipsed by the lower-than-expected revenue, possibly instigating a downward trend in the stock's value.
  • Concerns among investors about IDXX's future growth sustainability are palpable, with guidance adjustments contributing to the stock's market decline.

01.04.2025 - IDXX Stock was up 9.0%

  • IDEXX Laboratories has showcased an average annual return of 21.28% over the past 10 years.
  • The company boasts a market capitalization of $35.41 billion, indicating its market strength and resilience.
  • Today, IDXX experienced a bullish movement likely attributed to its consistent growth and robust financial performance that has attracted investors seeking high returns.

01.04.2025 - IDXX Stock was up 9.0%

  • Strong Q1 earnings were reported by IDXX, surpassing expectations and resulting in an increased outlook for the fiscal year 2025. This positive financial performance has led to heightened investor interest and a rise in the stock price.
  • Over the past decade, IDXX has consistently outperformed the market, achieving an impressive annualized return of 21.28%. This track record has likely fostered investor confidence in the company's future growth prospects.
  • The notable financial results and a history of market-beating returns have fueled a positive trend in IDXX stock, reflecting optimistic investor attitudes and confidence in the company's future prospects.

05.11.2023 - IDXX Stock was up 5.2%

  • The bullish movement in IDXX stock could be attributed to positive market sentiment and investor confidence in the company's growth prospects.
  • The fair valuation analysis mentioned in an article from GuruFocus might have highlighted the undervalued nature of IDXX stock, attracting more investors to buy shares.
  • The increased position of The Manufacturers Life Insurance Company, as mentioned in an article from EIN News Manufacturing, could have also contributed to the bullish movement, indicating institutional interest and support for the stock.

06.01.2024 - IDXX Stock was up 8.5%

  • IDXX stock had a strong bullish movement today, with an 8% jump.
  • The company reported better-than-expected fourth-quarter 2023 financial results, with adjusted EPS of $2.32, beating the consensus of $2.12.
  • The strong Q4 and full-year 2023 results contributed to the positive market movement.
  • Investors have taken a bullish approach towards IDXX, indicating confidence in the company's future prospects.

01.02.2024 - IDXX Stock was up 1.0%

  • IDXX has shown a strong bullish movement today.
  • The impressive long-term performance of IDXX, outperforming the market by 13.65% annually over the past 15 years, has been highlighted.
  • Investors may be reacting positively to the company's consistent growth and market outperformance, driving the bullish movement in the stock.
  • The long-term success and market capitalization of $47.73 billion further reinforce investor confidence in IDXX, contributing to today's bullish trend.

15.04.2024 - IDXX Stock was up 5.2%

  • Upgrading IDXX from a hold to a buy rating likely boosted investor confidence in the company's future prospects, leading to increased buying activity.
  • The announcement of IDEXX Laboratories' participation in the Stifel Jaws & Paws Conference and the 2024 Investor Day could have signaled to investors the company's commitment to innovation and growth, further driving up the stock price.
  • The leadership transition and shareholder approval news may have instilled confidence in investors regarding the company's strategic direction and stability, contributing to the bullish movement in the stock.
  • Overall, the combination of positive news catalysts, such as upgrades, conference participation, and leadership transitions, likely fueled the strong bullish movement in IDXX's stock price today.

17.06.2024 - IDXX Stock was up 5.1%

  • The bullish movement in IDXX stock today could be attributed to the positive P/E ratio insights, indicating potential undervaluation and attracting investors.
  • The comparison with another stock might have highlighted IDXX as a more favorable option, driving increased buying interest.
  • Despite the downgrade to a "Hold" rating, investors may have interpreted this as a neutral stance rather than a negative one, leading to a continued bullish sentiment in the market.
  • Overall, the combination of positive valuation metrics, comparative analysis, and the perceived neutral rating change likely contributed to the strong bullish movement in IDXX stock today.

06.07.2024 - IDXX Stock was up 5.3%

  • Following the impressive second-quarter results, IDXX stock demonstrated a bullish trend, surpassing estimates for both EPS and revenue.
  • The favorable earnings report, highlighted by exceeding EPS forecasts and revenue growth, likely enhanced investor confidence in the company's performance and future outlook.
  • Despite lowering its FY24 guidance in a separate update, the market primarily responded to the strong quarterly results, propelling a bullish sentiment in IDXX stock.
  • The failure to meet earnings and revenue projections in a different statement did not notably sway market sentiment towards IDXX today, as attention remained focused on the positive quarterly showing.

06.07.2024 - IDXX Stock was up 5.8%

  • Despite reducing its FY24 guidance and falling short of earnings projections, the robust revenue growth in the second quarter, notably in CAG and Water divisions, likely made a positive impression on investors.
  • The rescheduled earnings call possibly hinted at favorable developments or strategic changes within the company, prompting optimism among investors.
  • The market's positive response may suggest that investors are placing more emphasis on the company's future growth prospects and innovative solutions rather than immediate financial setbacks.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.